C12orf54
gene geneOn this page
Also known as MGC35033
Summary
C12orf54 (chromosome 12 open reading frame 54, HGNC:28553) is a protein-coding gene on chromosome 12q13.11, encoding Uncharacterized protein C12orf54 (Q6X4T0).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 8 total
- MANE Select transcript:
NM_152319
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28553 |
| Approved symbol | C12orf54 |
| Name | chromosome 12 open reading frame 54 |
| Location | 12q13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC35033 |
| Ensembl gene | ENSG00000177627 |
| Ensembl biotype | protein_coding |
| Entrez | 121273 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 2 nonsense_mediated_decay, 1 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000380491, ENST00000548364, ENST00000548913, ENST00000549398, ENST00000551266
RefSeq mRNA: 1 — MANE Select: NM_152319
NM_152319
CCDS: CCDS8764
Canonical transcript exons
ENST00000548364 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001213585 | 48488924 | 48488956 |
| ENSE00001213589 | 48486688 | 48486726 |
| ENSE00001213594 | 48486178 | 48486208 |
| ENSE00001213605 | 48483240 | 48483361 |
| ENSE00002217583 | 48482498 | 48482576 |
| ENSE00003530182 | 48490812 | 48490836 |
| ENSE00003578864 | 48492947 | 48492995 |
| ENSE00003692283 | 48494798 | 48494979 |
| ENSE00003750295 | 48496181 | 48496524 |
Expression profiles
Bgee: expression breadth ubiquitous, 170 present calls, max score 97.10.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0328 / max 27.5162, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 125263 | 0.0328 | 3 |
Top tissues by expression
236 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.10 | gold quality |
| left testis | UBERON:0004533 | 95.33 | gold quality |
| right testis | UBERON:0004534 | 95.19 | gold quality |
| testis | UBERON:0000473 | 92.58 | gold quality |
| pancreatic ductal cell | CL:0002079 | 85.00 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.96 | gold quality |
| endothelial cell | CL:0000115 | 82.95 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 82.50 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 82.49 | gold quality |
| kidney epithelium | UBERON:0004819 | 80.18 | gold quality |
| adult organism | UBERON:0007023 | 80.17 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 78.67 | gold quality |
| esophagus mucosa | UBERON:0002469 | 76.19 | gold quality |
| myocardium | UBERON:0002349 | 72.63 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 72.29 | gold quality |
| vagina | UBERON:0000996 | 72.05 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 71.79 | gold quality |
| gingival epithelium | UBERON:0001949 | 71.59 | silver quality |
| buccal mucosa cell | CL:0002336 | 70.23 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 70.13 | gold quality |
| left ovary | UBERON:0002119 | 69.18 | gold quality |
| tibialis anterior | UBERON:0001385 | 68.95 | silver quality |
| tibial nerve | UBERON:0001323 | 68.90 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 68.77 | silver quality |
| upper arm skin | UBERON:0004263 | 68.56 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 68.42 | gold quality |
| esophagus | UBERON:0001043 | 68.24 | gold quality |
| oral cavity | UBERON:0000167 | 68.18 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.56 | gold quality |
| ectocervix | UBERON:0012249 | 67.48 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 31.90 |
| E-ANND-3 | no | 3.02 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting C12orf54, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-4276 | 99.56 | 67.66 | 2514 |
| HSA-MIR-154-3P | 99.50 | 70.05 | 831 |
| HSA-MIR-487A-3P | 99.50 | 69.95 | 840 |
| HSA-MIR-548V | 99.29 | 69.47 | 1157 |
| HSA-MIR-502-5P | 98.77 | 66.51 | 906 |
| HSA-MIR-1-5P | 98.70 | 68.66 | 1017 |
| HSA-MIR-219B-5P | 97.91 | 65.80 | 531 |
| HSA-MIR-6793-3P | 97.66 | 65.78 | 1084 |
| HSA-MIR-890 | 97.47 | 68.67 | 982 |
| HSA-MIR-3157-5P | 97.41 | 67.61 | 998 |
| HSA-MIR-4288 | 97.11 | 67.23 | 1636 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Uncharacterized protein C12orf54 — Q6X4T0 (reviewed: Q6X4T0)
All UniProt accessions (3): C9IYT5, H0YIT5, Q6X4T0
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6X4T0-1 | 1 | yes |
| Q6X4T0-2 | 2 |
RefSeq proteins (1): NP_689532* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031465 | DUF4681 | Family |
Pfam: PF15732
UniProt features (9 total): compositionally biased region 3, region of interest 2, splice variant 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6X4T0-F1 | 68.06 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 17 (showing top):
FOXJ2_02, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, TAL1BETAITF2_01, RICKMAN_HEAD_AND_NECK_CANCER_E, KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES, MIR502_5P, BDP1_TARGET_GENES, GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN, GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP, GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP, ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP, chr12q13, ZID_01, GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN, AATGTGA_MIR23A_MIR23B
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
92 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C12orf54 | PAGE3 | Q5JUK9 | 662 |
| C12orf54 | MAGEB1 | P43366 | 570 |
| C12orf54 | ANP32D | O95626 | 480 |
| C12orf54 | VCX | Q9H320 | 446 |
| C12orf54 | MDH1B | Q5I0G3 | 435 |
| C12orf54 | KXD1 | Q9BQD3 | 418 |
| C12orf54 | PPDPF | Q9H3Y8 | 397 |
| C12orf54 | A0A0B4J2G0 | A0A0B4J2G0 | 393 |
| C12orf54 | TTLL3 | Q9Y4R7 | 392 |
| C12orf54 | SIPA1L2 | Q9P2F8 | 370 |
| C12orf54 | A0A0A6YYG9 | A0A0A6YYG9 | 370 |
| C12orf54 | MIPOL1 | Q8TD10 | 369 |
| C12orf54 | ZNF208 | O43345 | 336 |
| C12orf54 | PLAAT1 | Q9HDD0 | 323 |
| C12orf54 | DUOXA1 | Q1HG43 | 301 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0D9SF12, A2A8T7, A6H7E2, A6NF36, A6NFA0, A6NI87, E1C7U0, P03246, P03247, P0DO92, P14355, P14683, Q0VG49, Q1HVF6, Q32LN6, Q3KPU7, Q3KSS3, Q4V7D2, Q4ZG55, Q5DU28, Q5JX69, Q5JX71, Q5R7E2, Q5U4U4, Q642A3, Q6NRW0, Q6P1U0, Q6P4J6, Q6P9N1, Q6PEX7, Q6X4T0, Q7L3B6, Q7SYV9, Q7T346, Q80Y73, Q8BJS8, Q8CF25, Q8IWB6, Q8N6T0, Q8NCU1
Diamond homologs: Q3SZX7, Q6X4T0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
8 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1287 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:48492945:AG:A | acceptor_gain | 0.9900 |
| 12:48492946:GG:G | acceptor_gain | 0.9900 |
| 12:48492946:GGGAT:G | acceptor_gain | 0.9900 |
| 12:48492994:GG:G | donor_gain | 0.9900 |
| 12:48492995:GG:G | donor_gain | 0.9900 |
| 12:48492996:G:GG | donor_gain | 0.9900 |
| 12:48492996:GTA:G | donor_loss | 0.9900 |
| 12:48492997:T:A | donor_loss | 0.9900 |
| 12:48492998:A:AG | donor_loss | 0.9900 |
| 12:48494790:T:A | acceptor_gain | 0.9900 |
| 12:48494797:GAAGC:G | acceptor_gain | 0.9900 |
| 12:48494953:G:GT | donor_gain | 0.9900 |
| 12:48486686:A:AG | acceptor_gain | 0.9800 |
| 12:48486687:G:GG | acceptor_gain | 0.9800 |
| 12:48492940:A:AG | acceptor_gain | 0.9800 |
| 12:48492941:CTTTA:C | acceptor_loss | 0.9800 |
| 12:48492942:TTTAG:T | acceptor_loss | 0.9800 |
| 12:48492943:TTA:T | acceptor_loss | 0.9800 |
| 12:48492944:TA:T | acceptor_loss | 0.9800 |
| 12:48492945:A:AG | acceptor_gain | 0.9800 |
| 12:48492945:A:AT | acceptor_loss | 0.9800 |
| 12:48492945:AGG:A | acceptor_gain | 0.9800 |
| 12:48492946:G:GG | acceptor_gain | 0.9800 |
| 12:48492946:GGG:G | acceptor_gain | 0.9800 |
| 12:48494791:G:A | acceptor_gain | 0.9800 |
| 12:48492999:AGTGT:A | donor_loss | 0.9700 |
| 12:48494786:ATTTT:A | acceptor_gain | 0.9700 |
| 12:48494795:C:G | acceptor_gain | 0.9700 |
| 12:48494796:A:AG | acceptor_gain | 0.9700 |
| 12:48494797:G:GG | acceptor_gain | 0.9700 |
AlphaMissense
833 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:48486720:G:C | W43C | 0.981 |
| 12:48486720:G:T | W43C | 0.981 |
| 12:48488936:T:C | F50L | 0.981 |
| 12:48488938:T:A | F50L | 0.981 |
| 12:48488938:T:G | F50L | 0.981 |
| 12:48490813:T:C | L57P | 0.980 |
| 12:48486718:T:A | W43R | 0.976 |
| 12:48486718:T:C | W43R | 0.976 |
| 12:48488937:T:C | F50S | 0.967 |
| 12:48490821:G:C | D60H | 0.960 |
| 12:48490824:G:C | A61P | 0.958 |
| 12:48488950:A:C | Q54H | 0.948 |
| 12:48488950:A:T | Q54H | 0.948 |
| 12:48488928:T:C | L47P | 0.947 |
| 12:48486719:G:C | W43S | 0.946 |
| 12:48488925:T:A | V46E | 0.942 |
| 12:48490822:A:T | D60V | 0.936 |
| 12:48490822:A:C | D60A | 0.935 |
| 12:48490834:G:C | R64P | 0.927 |
| 12:48490825:C:A | A61D | 0.925 |
| 12:48488949:A:C | Q54P | 0.924 |
| 12:48490823:T:A | D60E | 0.924 |
| 12:48490823:T:G | D60E | 0.924 |
| 12:48488946:T:A | I53K | 0.921 |
| 12:48486716:T:C | L42P | 0.920 |
| 12:48488937:T:G | F50C | 0.916 |
| 12:48490836:G:T | G65W | 0.911 |
| 12:48488946:T:G | I53R | 0.909 |
| 12:48486704:T:G | I38S | 0.906 |
| 12:48490822:A:G | D60G | 0.906 |
dbSNP variants (sampled 300 via entrez): RS1000005821 (12:48439869 C>A), RS1000069556 (12:48460015 A>C), RS1000079048 (12:48460274 A>G), RS1000110506 (12:48445367 A>G), RS1000153605 (12:48482458 A>C,G), RS1000198688 (12:48450939 A>C), RS1000199491 (12:48465953 A>G), RS1000228266 (12:48454352 G>T), RS1000270761 (12:48414250 T>C), RS1000289335 (12:48434469 G>A), RS1000296745 (12:48495486 T>C), RS1000315043 (12:48489716 C>T), RS1000355023 (12:48450648 A>G), RS1000412913 (12:48419235 G>A,T), RS1000484927 (12:48479071 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010083_167 | Hemoglobin levels | 3.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| arsenite | decreases methylation | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Demecolcine | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Malathion | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Vincristine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.